Results: 1-25 | 26-46
Results: 1-25/46

Authors: Pittet, MJ Speiser, DE Valmori, D Rimoldi, D Lienard, D Lejeune, F Cerottini, JC Romero, P
Citation: Mj. Pittet et al., Ex vivo analysis of tumor antigen specific CD8(+) T cell responses using MHC/peptide tetramers in cancer patients, INT IMMUNO, 1(7), 2001, pp. 1235-1247

Authors: Romero, P Dutoit, V Rubio-Godoy, V Lienard, D Speiser, D Guillaume, P Servis, K Rimoldi, D Cerottini, JC Valmori, D
Citation: P. Romero et al., CD8(+) T-cell response to NY-ESO-1: Relative antigenicity and in vitro immunogenicity of natural and analogue sequences, CLIN CANC R, 7(3), 2001, pp. 766S-772S

Authors: Pittet, MJ Speiser, DE Lienard, D Valmori, D Guillaume, P Dutoit, V Rimoldi, D Lejeune, F Cerottini, JC Romero, P
Citation: Mj. Pittet et al., Expansion and functional maturation of human tumor antigen-specific CD8(+)T cells after vaccination with antigenic peptide, CLIN CANC R, 7(3), 2001, pp. 796S-803S

Authors: Rubio-Godoy, V Dutoit, V Rimoldi, D Lienard, D Lejeune, F Speiser, D Guillaume, P Cerottini, JC Romero, P Valmori, D
Citation: V. Rubio-godoy et al., Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life, P NAS US, 98(18), 2001, pp. 10302-10307

Authors: Sliz, P Michielin, O Cerottini, JC Luescher, I Romero, P Karplus, M Wiley, DC
Citation: P. Sliz et al., Crystal structures of two closely related but antigenically distinct HLA-A2/Melanocyte-Melanoma tumor-antigen peptide complexes, J IMMUNOL, 167(6), 2001, pp. 3276-3284

Authors: Speiser, DE Colonna, M Ayyoub, M Cella, M Pittet, MJ Batard, P Valmori, D Guillaume, P Lienard, D Cerottini, JC Romero, P
Citation: De. Speiser et al., The activatory receptor 2B4 is expressed in vivo by human CD8(+) effector alpha beta T cells, J IMMUNOL, 167(11), 2001, pp. 6165-6170

Authors: Blanchet, JS Valmori, D Dufau, I Ayyoub, M Nguyen, C Guillaume, P Monsarrat, B Cerottini, JC Romero, P Gairin, JE
Citation: Js. Blanchet et al., A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: Implication for molecular anti-melanoma immunotherapy, J IMMUNOL, 167(10), 2001, pp. 5852-5861

Authors: Miconnet, I Coste, I Beermann, F Haeuw, JF Cerottini, JC Bonnefoy, JY Romero, P Renno, T
Citation: I. Miconnet et al., Cancer vaccine design: A novel bacterial adjuvant for peptide-specific CTLinduction, J IMMUNOL, 166(7), 2001, pp. 4612-4619

Authors: Pittet, MJ Zippelius, A Speiser, DE Assenmacher, M Guillaume, P Valmori, D Lienard, D Lejeune, F Cerottini, JC Romero, P
Citation: Mj. Pittet et al., Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: Implicationsof a novel approach for T cell monitoring in infectious and malignant diseases, J IMMUNOL, 166(12), 2001, pp. 7634-7640

Authors: Rimoldi, D Muehlethaler, K Salvi, S Valmori, D Romero, P Cerottini, JC Levy, F
Citation: D. Rimoldi et al., Subcellular localization of the melanoma-associated protein Melan-A(MART-1) influences the processing of its HLA-A2-restricted epitope, J BIOL CHEM, 276(46), 2001, pp. 43189-43196

Authors: Ayyoub, M Migliaccio, M Guillaume, P Lienard, D Cerottini, JC Romero, P Levy, F Speiser, DE Valmori, D
Citation: M. Ayyoub et al., Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cellsfrom melanoma patients reveals inefficient antigen processing., EUR J IMMUN, 31(9), 2001, pp. 2642-2651

Authors: Doucey, MA Legler, DF Boucheron, N Cerottini, JC Bron, C Luescher, IF
Citation: Ma. Doucey et al., CTL activation is induced by cross-linking of TCR/MHC-peptide-CD8/p56(lck)adducts in rafts, EUR J IMMUN, 31(5), 2001, pp. 1561-1570

Authors: Speiser, DE Migliaccio, M Pittet, MJ Valmori, D Lienard, D Lejeune, F Reichenbach, P Guillaume, P Luscher, I Cerottini, JC Romero, P
Citation: De. Speiser et al., Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells, EUR J IMMUN, 31(2), 2001, pp. 459-466

Authors: Dietrich, PY Walker, PR Quiquerez, AL Perrin, G Dutoit, V Lienard, D Guillaume, P Cerottini, JC Romero, P Valmori, D
Citation: Py. Dietrich et al., Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptidewith diverse and nonoverlapping T-cell receptor repertoires, CANCER RES, 61(5), 2001, pp. 2047-2054

Authors: Valmori, D Dutoit, V Rubio-Godoy, V Chambaz, C Lienard, D Guillaume, P Romero, P Cerottini, JC Rimoldi, D
Citation: D. Valmori et al., Frequent cytolytic T-cell responses to peptide IMAGE-A10(254-262) in melanoma, CANCER RES, 61(2), 2001, pp. 509-512

Authors: Dutoit, V Rubio-Godoy, V Dietrich, PY Quiqueres, AL Schnuriger, V Rimoldi, D Lienard, D Speiser, D Guillaume, P Batard, P Cerottini, JC Romero, P Valmori, D
Citation: V. Dutoit et al., Heterogeneous T-cell response to MAGE-A10(254-262): High avidity-specific cytolytic T lymphocytes show superior antitumor activity, CANCER RES, 61(15), 2001, pp. 5850-5856

Authors: Pinilla, C Rubio-Godoy, V Dutoit, V Guillaume, P Simon, R Zhao, YD Houghten, RA Cerottini, JC Romero, P Valmori, D
Citation: C. Pinilla et al., Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes, CANCER RES, 61(13), 2001, pp. 5153-5160

Authors: Jeannin, P Renno, T Goetsch, L Miconnet, I Aubry, JP Delneste, Y Herbault, N Baussant, T Magistrelli, G Soulas, C Romero, P Cerottini, JC Bonnefoy, JY
Citation: P. Jeannin et al., OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway, NAT IMMUNOL, 1(6), 2000, pp. 502-509

Authors: Morel, S Levy, F Burlet-Schiltz, O Brasseur, F Probst-Kepper, M Peitrequin, AL Monsarrat, B Van Velthoven, R Cerottini, JC Boon, T Gairin, JE Van den Eynde, BJ
Citation: S. Morel et al., Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells, IMMUNITY, 12(1), 2000, pp. 107-117

Authors: Migliaccio, M Amacker, M Just, T Reichenbach, P Valmori, D Cerottini, JC Romero, P Nabholz, M
Citation: M. Migliaccio et al., Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8(+) lymphocyte immortalization, J IMMUNOL, 165(9), 2000, pp. 4978-4984

Authors: Brawand, P Lemonnier, FA MacDonald, HR Cerottini, JC Held, W
Citation: P. Brawand et al., Transgenic expression of Ly49A on T cells impairs a specific antitumor response, J IMMUNOL, 165(4), 2000, pp. 1871-1876

Authors: Rimoldi, D Rubio-Godoy, V Dutoit, V Lienard, D Salvi, S Guillaume, P Speiser, D Stockert, E Spagnoli, G Servis, C Cerottini, JC Lejeune, F Romero, P Valmori, D
Citation: D. Rimoldi et al., Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma, J IMMUNOL, 165(12), 2000, pp. 7253-7261

Authors: Valmori, D Dutoit, V Lienard, D Lejeune, F Speiser, D Rimoldi, D Cerundolo, V Dietrich, PY Cerottini, JC Romero, P
Citation: D. Valmori et al., Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8(+) T cells in melanoma patients, J IMMUNOL, 165(1), 2000, pp. 533-538

Authors: Pittet, MJ Speiser, DE Valmori, D Cerottini, JC Romero, P
Citation: Mj. Pittet et al., Cutting edge: Cytolytic effector function in human circulating CD8(+) T cells closely correlates with CD56 surface expression, J IMMUNOL, 164(3), 2000, pp. 1148-1152

Authors: Valmori, D Levy, F Miconnet, I Zajac, P Spagnoli, GC Rimoldi, D Lienard, D Cerundolo, V Cerottini, JC Romero, P
Citation: D. Valmori et al., Induction of potent antitumor CTL responses by recombinant vaccinia encoding a Melan-A peptide analogue, J IMMUNOL, 164(2), 2000, pp. 1125-1131
Risultati: 1-25 | 26-46